Avanir Pharmaceuticals Inc. v. Par Pharmaceutical Inc.

U.S. Court of Appeals for the Federal Circuit

Avanir Pharmaceuticals Inc. v. Par Pharmaceutical Inc.

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

AVANIR PHARMACEUTICALS INC., Plaintiff-Appellee

AVANIR HOLDING COMPANY, CENTER FOR NEUROLOGICAL STUDY, Plaintiffs

v.

PAR PHARMACEUTICAL INC., PAR PHARMACEUTICAL COMPANIES INC., Defendants-Appellants ______________________

2014-1838 ______________________

Appeal from the United States District Court for the District of Delaware in No. 1:11-cv-00704-LPS, Chief Judge Leonard P. Stark. ______________________

JUDGMENT ______________________

F. DOMINIC CERRITO, Quinn Emanuel Urquhart & Sullivan, LLP, New York, NY, argued for plaintiff- appellee. Also represented by ERIC C. STOPS, EVANGELINE SHIH, DANIEL C. WIESNER. JANINE A. CARLAN, Arent Fox, LLP, Washington, DC, argued for defendants-appellants. Also represented by RICHARD J. BERMAN, AZIZ BURGY, TANIEL ERMANO ANDERSON, STEPHEN YANG. ______________________

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (CHEN, LINN, and HUGHES, Circuit Judg- es). AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

August 10, 2015 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court

Reference

Status
Unpublished